LiquiVida Wellness Therapy Franchise For Sale
Liquivida® is the leader in the IV vitamin therapy industry and is fully diversified in its products and services. It serves customer needs ranging from anti-aging, medical aesthetics, and weight loss, along with personal beauty and care.
The US healthcare industry is broken. But we’re partnering with the best in modern medicine to make a difference in our communities and around the world. By focusing on the larger population, we believe we can proactively keep people healthy, so they can live more active and fulfilling lifestyles.
Why LiquVida?
· Proprietary Custom I.V. Drip Technology
· Multiple Revenue Streams: Products & Services
· Comprehensive Training & Ongoing Support
· Program Affiliated with Over 4000 Doctors
· No Medical License Required
· Membership model
· Multiple revenue streams
Clothing & Shoe Stores for Sale
Cleaning & Janitorial Businesses for Sale
Startup Investment Opportunities
Service Businesses for Sale
Warehouse & Storage Businesses for Sale
Employment & Personnel Businesses for Sale
Dollar Stores for Sale
Construction & Landscaping Businesses for Sale
Bars, Pubs & Nightclubs for Sale
Vending & Kiosk Businesses for Sale
Advertising & Promotional Franchises for Sale
Construction & Landscaping Franchise Opportunities
Furniture & Home Decor Franchise Opportunities
Smoke & Vape Shop Franchises for Sale
Technology Franchise Opportunities
Post Office Franchises for Sale
Pet Franchise Opportunities
Entertainment & Recreation Franchise Opportunities
Printing, Signs & Publishing Franchise Opportunities
Transport & Shipping Franchise Opportunities
Office Buildings for Sale or Rent
Industrial Buildings for Sale or Lease
Retail Buildings for Sale or Lease
Medical Office Spaces for Sale or Rent
Retail Spaces for Lease or Sale
Plazas for Sale
Mixed Use Buildings for Sale or Rent
Commercial Buildings for Sale or Lease
Medical Buildings for Sale or Lease
Houses & Condos for Sale or Lease
An email will be sent to registered email address.
Please select if you are: